Molecular Mechanism of Astragaloside IV in Improving Endothelial Dysfunction of Cardiovascular Diseases Mediated by Oxidative Stress
Endothelial dysfunction, induced by oxidative stress, is an essential factor affecting cardiovascular disease. Uncoupling of endothelial nitric oxide synthase (eNOS) leads to a decrease in nitric oxide (NO) production, an increase in reactive oxygen species (ROS) production, NO consumption, and NO s...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d17ae168b17d41389f66aa75dad7adec |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d17ae168b17d41389f66aa75dad7adec |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d17ae168b17d41389f66aa75dad7adec2021-11-29T00:56:47ZMolecular Mechanism of Astragaloside IV in Improving Endothelial Dysfunction of Cardiovascular Diseases Mediated by Oxidative Stress1942-099410.1155/2021/1481236https://doaj.org/article/d17ae168b17d41389f66aa75dad7adec2021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/1481236https://doaj.org/toc/1942-0994Endothelial dysfunction, induced by oxidative stress, is an essential factor affecting cardiovascular disease. Uncoupling of endothelial nitric oxide synthase (eNOS) leads to a decrease in nitric oxide (NO) production, an increase in reactive oxygen species (ROS) production, NO consumption, and NO synthesis. As a main active ingredient of astragalus, astragaloside IV can reduce the apoptosis of endothelial cells during oxidative stress. This review is aimed at exploring the mechanism of astragaloside IV in improving oxidative stress-mediated endothelial dysfunction relevant to cardiovascular diseases. The findings showed that the astragaloside IV can prevent or reverse the uncoupling of eNOS, increase eNOS and NO, and enhance several activating enzymes to activate the antioxidant system. In-depth validation and quantitative experiments still need to be implemented.Peipei MengRui YangFenjun JiangJianbo GuoXinyu LuTao YangQingyong HeHindawi LimitedarticleCytologyQH573-671ENOxidative Medicine and Cellular Longevity, Vol 2021 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Cytology QH573-671 |
spellingShingle |
Cytology QH573-671 Peipei Meng Rui Yang Fenjun Jiang Jianbo Guo Xinyu Lu Tao Yang Qingyong He Molecular Mechanism of Astragaloside IV in Improving Endothelial Dysfunction of Cardiovascular Diseases Mediated by Oxidative Stress |
description |
Endothelial dysfunction, induced by oxidative stress, is an essential factor affecting cardiovascular disease. Uncoupling of endothelial nitric oxide synthase (eNOS) leads to a decrease in nitric oxide (NO) production, an increase in reactive oxygen species (ROS) production, NO consumption, and NO synthesis. As a main active ingredient of astragalus, astragaloside IV can reduce the apoptosis of endothelial cells during oxidative stress. This review is aimed at exploring the mechanism of astragaloside IV in improving oxidative stress-mediated endothelial dysfunction relevant to cardiovascular diseases. The findings showed that the astragaloside IV can prevent or reverse the uncoupling of eNOS, increase eNOS and NO, and enhance several activating enzymes to activate the antioxidant system. In-depth validation and quantitative experiments still need to be implemented. |
format |
article |
author |
Peipei Meng Rui Yang Fenjun Jiang Jianbo Guo Xinyu Lu Tao Yang Qingyong He |
author_facet |
Peipei Meng Rui Yang Fenjun Jiang Jianbo Guo Xinyu Lu Tao Yang Qingyong He |
author_sort |
Peipei Meng |
title |
Molecular Mechanism of Astragaloside IV in Improving Endothelial Dysfunction of Cardiovascular Diseases Mediated by Oxidative Stress |
title_short |
Molecular Mechanism of Astragaloside IV in Improving Endothelial Dysfunction of Cardiovascular Diseases Mediated by Oxidative Stress |
title_full |
Molecular Mechanism of Astragaloside IV in Improving Endothelial Dysfunction of Cardiovascular Diseases Mediated by Oxidative Stress |
title_fullStr |
Molecular Mechanism of Astragaloside IV in Improving Endothelial Dysfunction of Cardiovascular Diseases Mediated by Oxidative Stress |
title_full_unstemmed |
Molecular Mechanism of Astragaloside IV in Improving Endothelial Dysfunction of Cardiovascular Diseases Mediated by Oxidative Stress |
title_sort |
molecular mechanism of astragaloside iv in improving endothelial dysfunction of cardiovascular diseases mediated by oxidative stress |
publisher |
Hindawi Limited |
publishDate |
2021 |
url |
https://doaj.org/article/d17ae168b17d41389f66aa75dad7adec |
work_keys_str_mv |
AT peipeimeng molecularmechanismofastragalosideivinimprovingendothelialdysfunctionofcardiovasculardiseasesmediatedbyoxidativestress AT ruiyang molecularmechanismofastragalosideivinimprovingendothelialdysfunctionofcardiovasculardiseasesmediatedbyoxidativestress AT fenjunjiang molecularmechanismofastragalosideivinimprovingendothelialdysfunctionofcardiovasculardiseasesmediatedbyoxidativestress AT jianboguo molecularmechanismofastragalosideivinimprovingendothelialdysfunctionofcardiovasculardiseasesmediatedbyoxidativestress AT xinyulu molecularmechanismofastragalosideivinimprovingendothelialdysfunctionofcardiovasculardiseasesmediatedbyoxidativestress AT taoyang molecularmechanismofastragalosideivinimprovingendothelialdysfunctionofcardiovasculardiseasesmediatedbyoxidativestress AT qingyonghe molecularmechanismofastragalosideivinimprovingendothelialdysfunctionofcardiovasculardiseasesmediatedbyoxidativestress |
_version_ |
1718407674940358656 |